AI Applied to Apple Watch ECG Can ID Ejection Fraction ≤40 Percent

FRIDAY, May 13, 2022 (HealthDay News) -- Single-lead electrocardiograms (ECGs) from an Apple watch interpreted by an artificial intelligence (AI) algorithm can identify ejection fraction ≤40 percent, according to a study presented at the annual meeting of the Heart Rhythm Society, held from April 29 to May 1 in San Francisco.
Itzhak Zachi Attia, Ph.D., from the Mayo Clinic in Rochester, Minnesota, and colleagues enrolled and followed subjects to examine the use of a single-lead Apple watch ECG for screening and monitoring individuals. A total of 2,454 individuals downloaded the study app. Watch ECGs acquired within one month of a clinically ordered echocardiogram were analyzed for the presence of ejection fraction ≤40 percent by AI using a single-lead model.
Subjects were enrolled from 46 states and 11 countries. The researchers found that 92 percent of participants used the app more than once (average, 2.1/month). Subjects sent 125,610 ECGs between August 2021 and February 2022. Overall, 421 subjects had at least one sinus rhythm ECG within 30 days of an echocardiogram. Of these, 16 (3.8 percent) had an ejection fraction ≤40 percent. Thirteen of the 16 patients with low ejection fraction were identified by the watch AI ECG, which had an area under the receiver operating characteristic curve of 0.875, and sensitivity and specificity of 81.2 and 81.3 percent, respectively.
"While our data are early, the test had an area under the curve of 0.88, meaning it is as good as or slightly better than a medical treadmill test," Attia said in a statement. "AI analysis of the watch ECG is a powerful test to identify a weak heart pump."
Related Posts
California Will Produce Its Own Insulin to Bring Down Prices
FRIDAY, July 8, 2022 (HealthDay News) -- California Governor Gavin Newsom...
Unos expertos recomiendan que todas las mujeres se hagan mamografías a partir de los 40 años
MARTES, 9 de mayo de 2023 (HealthDay News) -- Un influyente panel de médicos...
FDA Approves First Pill for Fecal Transplant Therapy
THURSDAY, April 27, 2023 (HealthDay News) – The U.S. Food and Drug...
Rubella Elimination Likely to Be Achievable in All Countries
FRIDAY, Sept. 30, 2022 (HealthDay News) -- Rubella elimination is likely to be...